Leadership: Page 25
-
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Dr. Rob Kotin Seeing the Big Picture in Gene Therapy Driven to innovate by Curiosity One of the most influential thought leaders in gene therapy today, Rob Kotin, Ph.D.’s work has the potential to make a lasting impact on the lives of patients suffering from debilitating diseases of the central n...
By PharmaVoice Team • Nov. 6, 2014 -
PharmaVoice Team/PharmaVoice
A New Era of Collaboration: Knowledge Sharing
To innovate in an efficient, cost-effective, and timely manner in today’s drug development environment, companies won’t be able to go it alone; they will need to share data and collaborate in new ways. There was a time when a drugmaker would own and guard every aspect of its research and developm...
By PharmaVoice Team • Sept. 27, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including special discounts Coming Attractions The Healthcare Businesswomen’s Assocation is holding its annual conference at the Chicago Hilton, Nov. 12-14, 2014. The conference ‚- Inspired Leaders. Powering Innovation. ‚- is expected draw more than 1...
By PharmaVoice Team • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
ACA Expands Pharma Market
Prescription drug coverage through the ACA’s health exchanges includes 8 million patients. While this is an opportunity for the pharmaceutical industry, it also puts more focus on value, costs, and outcomes. Pharmaceutical companies are finding a changed market for prescription drugs now that con...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Trial Solutions: The Upside of Clinical Solutions
Even as pharmaceutical companies and their development partners continue to grapple with bringing safe products to market on time and on budget, new technologies, models, and analytics are driving improvements to counter the industry’s challenges. According to R&D leaders who recently partici...
By PharmaVoice Team • May 29, 2014 -
PharmaVoice Team/PharmaVoice
The Change Agents
The Change Agents Jessica BruEggeman Changing Health Behavior with Insight and Compassion Passionate and knowledgeable about her belief that changing health behavior can lead to improved health outcomes, Jessica Brueggeman succeeds in making a believer out of anyone who comes within her sphere of...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
The Entrepreneurs
The Entrepreneurs Amy Ellis Fearless Innovation Drawing on her highly successful new product development skills in consumer products, Amy Ellis embarked on an ambitious journey: to resolve one of the industry’s most intractable problems, the unsustainably high rate of inconclusive CNS trials. Wit...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
2013 PharmaVOICE 100 - Who's on the List by Company
2013 PharmaVOICE 100 – Who’s on the List by Company Indexed by Company Affiliation Accelrys Ken Rapp Acorda Therapeutics Denise Duca Acurian Kristin Gross Addgene Dr. Joanne Kamens Advanced Clinical Concepts David Rear Agano Solutions and Auditgraph Mauricha Marcussen AmerisourceBergen Corp. Stev...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter from the Editor By Taren Grom The 2013 PharmaVOICE 100 Each year we have the privilege of showcasing 100 of the most inspiring and motivational individuals throughout the life-sciences industry. This special issue, now in its ninth year, once again showcases the individuals as identified b...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Count Down to the Sunshine Act
Count Down to Sunshine Act The final rule for tracking physician payments under the Sunshine Act has provided needed clarity, but questions remain about data accuracy and the public’s ability to interpret the information. The pharmaceutical industry now has some guidance on how to report payments...
By Denise Myshko • May 29, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
June 17-18 Gross to Net Accounting Forum for Pharmaceutical Manufacturers Hyatt Harbor Side, Boston Institute for International Research, iirusa.comJune 17-19 Next-Gen Kinase Inhibitors The Revere Hotel, Boston Cambridge Healthtech Institute, healthtech.com/kin/ June 18 5th Annual Cloud Slam 2013...
By Heather Hummel • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Medical Affairs: The Catalyst for Effective Medical Communications
It has been said knowledge is power. Throughout the ages, healthcare professionals have been revered as powerful not only for their medical acumen but for the ability to heal the sick. Today as therapeutic options become more complex, physicians need to continually update and expand their knowled...
By Debra Joyce • March 28, 2013 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Medical Affairs: Beyond the Science
Beyond the Science By Taren Grom Medical affairs professionals are integral to creating new bridges that cross internal departments and connect to new stakeholders to share the increasing amount of scientific information available. With the current healthcare system requiring more data, quality e...
By Taren Grom • March 28, 2013 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Outsourcing For Efficiency
Outsourcing for Efficiency For many sponsor companies in the life-sciences industry engaging with outsourcing partners — from the clinic to the market — is imperative if they want to drive efficiencies in time, money, and personnel as well as innovation. Life-sciences companies can reap the many ...
By Taren Grom • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
C-Suite: Specialty Pharma
Specialty Pharma Targeted Opportunities C-Suite: Specialty Pharma By Taren Grom The growing U.S. specialty pharmaceuticals market is comprised of more than 90 companies marketing more than 550 prescription pharmaceutical products, according to MCD Group, and dozens of therapeutic categories, incl...
By Taren Grom • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
Sales: New Strategies
Sales of the Future: New Tools, New Roles, New Strategies Salesforces target smaller audiences, with more customer service. Threatened by downsizing and mergers, disrupted by managed-care policies, and stalled by no-see physicians — the list on the challenges facing today’s sales reps goes on and...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Marketing: Public Relations
PR Goes Digital With the advent of digital media, the role of public relations has a greater responsibility to manage and protect a company’s reputation, while increasing visibility. According to Rob Bazemore, president, Janssen Biotech, PR plays a valuable role in building and maintaining the vi...
By Robin Robinson • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Regulatory Affairs: Regulating the Globe
The growing pressure on pharma companies and regulators to ensure and enforce product potency and safety has resulted in a strong trend toward harmonization among regulatory bodies throughout the world. “Regulatory professionals can no longer operate with a local-only mentality; every product and...
By Carolyn Gretton • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
China's Pharma Star Shines Bright
With a large patient population, government commitment to healthcare reform, a huge depth of scientific talent, and a powerful economy, China has been identified by many as the world’s most important emerging biopharma market. With a population of 1.3 billion people, China is both the world’s mos...
By Kim Ribbink • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Take Charge of Your Career: Next Steps
Experts discuss the importance of mentoring, sponsorship, and coaching in career development. Mentoring has been a common tool to help employees learn from and take advantage of the experience of others. A consensus among our experts is that all employees can benefit from having mentors at differ...
By Denise Myshko • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
France Puts Health on the Map
France is renowned for the quality of its healthcare system, competitive R&D environment, and worldwide translational medicine centers of excellence in several disease states. By Kim Ribbink France is a leading light in the area of healthcare and pharmaceuticals. Today, France is the secon...
By PharmaVoice Team • March 26, 2012 -
PharmaVoice Team/PharmaVoice
Safety and Pharmacovigilance: A Moving Target
Robin Robinson The industry has always been under extreme scrutiny by regulators and the public, but the current business environment creates even more pressure on the pharmaceutical industry to stay compliant. Regulations and procedures are not only tightening but continually developing and c...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
The Entrepreneurs
Matthew Baker Compass IRB LLC William Buzzeo Cegedim Compliance Solutions Prabhavathi Fernandes Cempra Pharmaceuticals Sander Flaum Flaum Idea Group Joy Frestedt Frestedt Inc. Michael Jirousek, Ph.D. Catabasis Pharmaceuticals Mark Lacy Benchmark Research Lance Nickens The Patient Recruiting Agenc...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
CSR Gets a Makeover
Corporate social responsibility (CSR) policies have been in place for decades at most companies, but the increased social awareness of today’s consumers has stepped up the visibility of such programs. The state of the world’s economy, the ever-evolving business environment, and an overall growth ...
By PharmaVoice Team • May 24, 2011
Previous
